BioNeutra Global Corporation (TSXV:BGA)
Canada
· Delayed Price · Currency is CAD 0.0300
0.00 (0.00%)
Jun 27, 2025, 4:00 PM EDT
BioNeutra Global Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| 10.86 | 11.38 | 13.39 | 15.4 | 24.12 | 37.7 | Upgrade
| |
Revenue Growth (YoY) | -3.62% | -15.00% | -13.05% | -36.14% | -36.03% | -0.04% | Upgrade
|
Cost of Revenue | 6.21 | 7.24 | 11.04 | 12.51 | 20.17 | 37.06 | Upgrade
|
Gross Profit | 4.65 | 4.14 | 2.35 | 2.89 | 3.94 | 0.64 | Upgrade
|
Selling, General & Admin | 5.14 | 4.83 | 4.63 | 5.32 | 6.56 | 8.14 | Upgrade
|
Research & Development | 0.1 | 0.15 | -0.02 | 0.01 | 0.26 | 0.44 | Upgrade
|
Operating Expenses | 5.46 | 5.24 | 4.82 | 6.13 | 7.55 | 9.42 | Upgrade
|
Operating Income | -0.81 | -1.1 | -2.47 | -3.24 | -3.6 | -8.78 | Upgrade
|
Interest Expense | -0.79 | -0.7 | -0.45 | -0.39 | -0.43 | -0.6 | Upgrade
|
Interest & Investment Income | 0.28 | 0.12 | 0 | 0 | 0 | 0 | Upgrade
|
Currency Exchange Gain (Loss) | -0.01 | -0.09 | 0.04 | -0.09 | -0.09 | -1.06 | Upgrade
|
EBT Excluding Unusual Items | -1.32 | -1.77 | -2.88 | -3.71 | -4.12 | -10.43 | Upgrade
|
Gain (Loss) on Sale of Assets | 0.04 | 0.04 | -0.04 | - | -0.1 | - | Upgrade
|
Legal Settlements | - | - | - | - | - | -0.64 | Upgrade
|
Other Unusual Items | 0.67 | -0.38 | - | 0.88 | 0.44 | -1.94 | Upgrade
|
Pretax Income | -0.61 | -2.11 | -2.92 | -2.83 | -3.77 | -13.02 | Upgrade
|
Income Tax Expense | - | - | - | - | -0.06 | -0.58 | Upgrade
|
Net Income | -0.61 | -2.11 | -2.92 | -2.83 | -3.71 | -12.44 | Upgrade
|
Net Income to Common | -0.61 | -2.11 | -2.92 | -2.83 | -3.71 | -12.44 | Upgrade
|
Shares Outstanding (Basic) | 46 | 46 | 46 | 46 | 46 | 46 | Upgrade
|
Shares Outstanding (Diluted) | 46 | 46 | 46 | 46 | 46 | 46 | Upgrade
|
Shares Change (YoY) | - | - | - | - | - | 0.19% | Upgrade
|
EPS (Basic) | -0.01 | -0.05 | -0.06 | -0.06 | -0.08 | -0.27 | Upgrade
|
EPS (Diluted) | -0.02 | -0.05 | -0.06 | -0.06 | -0.08 | -0.27 | Upgrade
|
Free Cash Flow | -0.57 | 0.66 | 0.72 | -0.39 | 1.4 | 0.56 | Upgrade
|
Free Cash Flow Per Share | -0.01 | 0.01 | 0.01 | -0.01 | 0.03 | 0.01 | Upgrade
|
Gross Margin | 42.84% | 36.40% | 17.54% | 18.77% | 16.36% | 1.69% | Upgrade
|
Operating Margin | -7.43% | -9.66% | -18.42% | -21.03% | -14.94% | -23.30% | Upgrade
|
Profit Margin | -5.62% | -18.52% | -21.82% | -18.37% | -15.37% | -33.01% | Upgrade
|
Free Cash Flow Margin | -5.28% | 5.83% | 5.37% | -2.53% | 5.82% | 1.50% | Upgrade
|
EBITDA | -0.35 | -0.04 | -1.41 | -1.97 | -1.82 | -6.51 | Upgrade
|
EBITDA Margin | -3.22% | -0.37% | -10.53% | -12.79% | -7.53% | -17.27% | Upgrade
|
D&A For EBITDA | 0.46 | 1.06 | 1.06 | 1.27 | 1.79 | 2.27 | Upgrade
|
EBIT | -0.81 | -1.1 | -2.47 | -3.24 | -3.6 | -8.78 | Upgrade
|
EBIT Margin | -7.43% | -9.66% | -18.42% | -21.03% | -14.94% | -23.30% | Upgrade
|
Updated Nov 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.